Record 5866   View: Standard Glossary  HistCite Guide
Author(s): TEZUKA M; SADANOBU S; GOMI K; TACHIKAWA M; SAWAMURA R
Title: IN-VITRO EFFECT OF CHROMIUM AND OTHER TRACE-METALS ON MOUSE HEPATOTOXICITY INDUCED BY CARBON-TETRACHLORIDE EXPOSURE
Source: BIOLOGICAL & PHARMACEUTICAL BULLETIN 18 (2): 256-261
Date: 1995 FEB
Document Type: Journal : Article
DOI:  
Language: English
Comment:  
Address:  
Reprint: TEZUKA, M, NIHON UNIV,COLL PHARM,DEPT HYG CHEM,7-7-1
NARASHINODAI,FUNABASHI,CHIBA 274,JAPAN.
E-mail:  
Author Keywords: CHROMIUM; PROTECTIVE EFFECT; PRIMARY CULTURED HEPATOCYTE; MOUSE; CARBON TETRACHLORIDE; HEPATOTOXICITY
KeyWords Plus: HEPATIC MICROSOMES; METABOLISM; BINDING; QUANTITATION; HEPATOCYTES; REDUCTION; TOXICITY; GROWTH; ASSAY; MICE
Abstract: Using primary cultured mouse hepatocytes , in vitro study was performed to discuss the effect of Cr(III) and several other trace metals, Cr(VI), Mn(II), Zn(II), Co(II), Cu(II), Ni(II), and Ga(III) on acute liver damage induced by CCl4 exposure. 1) The LDH activity 60min after CCl4 exposure increased dose-dependently with CCl4 concentrations in all of the trace metal pretreatment groups, except for the Cr(VI) pretreatment group, which showed a significant protective effect even after 30 min of CCl4 exposure. 2) LDH leakage was not observed 10min after CCl4 exposure at 3 or 5 mM, while Lipid peroxidation was increased dose-dependently with CCl4 concentrations in all groups except the Cr(VI) pretreatment group, in which the production of peroxidated lipid was significantly inhibited. 3) Similarly to the pretreatment with Cr(VI), LDH leakage 30min after exposure to 5mM CCl4 was inhibited by pretreatment with such antoxidants as N,N'-diphenyl-p-phenylenediamine or DL-alpha-tocopherol. 4) The Cr(VI) uptake was about 50% of the added amount, whereas the Cr(III) uptake was only 5% of the added amount. 5) 90% or more of the intracellular chromium was reduced to Cr(III) 10min after Cr(VI) treatment. The results suggested that the in vitro protective effect of pretreatment with Cr(VI) was due to a rapid reduction of Cr(VI) to Cr(III), and the radical scavenger-like effect of the produced Cr(III) was the same effect as in vivo Cr(III); it therefore suggests that Cr(III) contributes to protective effect on CCl4-induced hepatotoxicity.
Cited References:
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248
BRATTIN WJ, 1985, J FREE RADICALS BIOL, V1, P27
BUEGE JA, 1978, METHOD ENZYMOL, V52, P302
FURUNO K, 1994, BIOL PHARM BULL, V17, P419
GAO M, 1993, TOXICOLOGY, V77, P171
GREEN LM, 1984, J IMMUNOL METHODS, V70, P257
ICHO T, 1994, BIOL PHARM BULL, V17, P914
JENNETTE KW, 1979, BIOL TRACE ELEMENT R, V1, P55
JENNETTE KW, 1981, ENV HLTH PERSPECT, V40, P233
MCCAY PB, 1984, J BIOL CHEM, V259, P2135
MIKALSEN A, 1991, CARCINOGENESIS, V12, P825
MOSHTAGHIE AA, 1992, BIOL TRACE ELEM RES, V32, P39
MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55
NAKAMURA T, 1985, CELL BIOL TOXICOL, V1, P285
PRATT PF, 1993, CARCINOGENESIS, V14, P2051
RECKNAGEL RO, 1967, PHARMACOL REV, V19, P145
SEGLEN PO, 1976, METHOD CELL BIOL, V13, P29
SHIMADA T, 1973, EISEI KAGAKU, V19, P35
SIPES IG, 1977, LIFE SCI, V20, P1541
SUZUKI T, 1994, BIOL PHARM BULL, V17, P82
TEZUKA M, 1991, J INORG BIOCHEM, V42, P1
TEZUKA M, 1991, J INORG BIOCHEM, V44, P261
WIEGAND HJ, 1984, TOXICOLOGY, V33, P341
WOLF CR, 1980, MOL PHARMACOL, V18, P553
WROBLEWSKI F, 1955, P SOC EXP BIOL MED, V90, P210